Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Metoclopramide for Nausea and Vomiting in the ED
NCT00778011Phase 4Completed
- Sponsor
- WellSpan Health
- Start
- Nov 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron in nausea ((none)) and Vomiting (3 arms), sponsored by WellSpan Health. Primary endpoint: Efficacy in nausea and vomiting treatment at 30 minutes. Started Nov 2005; status: completed.
02
Drugs
ondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00778011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00778011.